$CASC Cascadian Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Cascadian Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Cascadian Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Cascadian Therapeutics, Inc. for free.

CIK Number: 0001412067
IRS Number: 260868560
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Trading Symbol: CASC
Company Address: 3101 WESTERN AVE. SUITE 600 SEATTLE 98121
Phone number: (206) 801-2100
Former name: Biomira CORP, date of change: 2007-09-11
Former name: Oncothyreon Inc., date of change: 2007-09-27

Prev close: $1.21
Average Daily Volume: 1,002,310
Days Low: $0.00
Year Low: $0.90
Year High: $4.11

Cascadian Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD0.00130,00000
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD0.0012,00000
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD0.007,80000
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD3.9950,000199,5000
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD4.6435,100162,8640
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD6.9020,834143,7550
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD6.908,33457,5050
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD21.065,834122,8640
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD10.561,25013,2000
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD10.442,50026,1000
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD28.441,25035,5500
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD41.5233413,8680
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...Option ExerciseD35.882,50089,7000
Mar 13 2018CASCCascadian Therapeu ...Walker Luke NathanielSVP, Clinical Devel ...SellU0.0010,3150010.3 K to 0 (-100.00 %)
Mar 13 2018CASCCascadian Therapeu ...James Steven PDirectorOption ExerciseD0.0013,92700

View all Cascadian Therapeutics, Inc. insider transactions.